Nomination period for the Broermann Medical Innovation Award started

Share

Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields

Gießen, January 17, 2025. The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.
The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.

The international Broermann Medical Innovation Award recognizes research results that demonstrate a high level of innovation for clinical application and thus have the potential to improve the lives and health of millions of people worldwide. The prize is aimed at scientists whose research has been pioneering in the fields of medicine, biotechnology, or related sciences.

The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, the founder of the Asklepios Kliniken. The Broermann gemeinnützige GmbH sponsors the award, and the University Hospital Giessen and Marburg (UKGM) manages the organization. “With this award, we want to honor groundbreaking medical discoveries and highlight those whose research brings real improvements in the prevention or treatment of diseases,” says Prof. Werner Seeger, Chairman of the Award Committee. For the Medical Director of the UKGM, Prof. Friedrich Grimminger, the unique prize reflects the clear conviction of the company founder: “Scientific excellence in medicine is always an international team effort, but without the genius of individual researchers, networks are limited in their impact. These key players and drivers of medical innovation should be promoted and recognized worldwide.”

Nomination process and deadlines
Nominations for the Broermann Medical Innovation Award can be submitted until March 1, 2025. The incumbent Hessian Minister President will present the award in December 2025 at the Hessian State Chancellery in Wiesbaden.

Further information on the award, the nomination criteria, and the selection process can be found at www.broermann-award.org

For further information, please contact

Broermann Medical Innovation Award
Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org


Asklepios Kliniken
Corporate Communications and Marketing
Tel.: + 49 (0) 40 / 18 18-82 66 36 
E-Mail: presse@asklepios.com
24-hour on-call service for the press office: +49 (0) 40 / 1818-82 8888

Visit Asklepios on the Internet, Facebook or YouTube:
www.asklepios.com
www.asklepios.com/konzern/gesundheitsmagazin 
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken 

RHÖN-KLINIKUM AG
Corporate Communications and Marketing
Heike Ochmann
Press Spokeswoman
Tel.: +49 (0) 9771 / 65-12130 
E-Mail: heike.ochmann@rhoen-klinikum-ag.com  

MEDICLIN AG
Dr. Janina Lossen
Press Spokeswoman
Tel:. +49 (0) 781 / 488-180
E-Mail: presse@mediclin.de

UKGM
Frank Steibli
Head of Communications and Press Spokesman 
Tel.: +49 (0) 641 / 985-51020
Mobile: +49 (0) 160 / 7120456
E-Mail: frank.steibli@uk-gm.de 

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Change in leadership at Visable: Patrick Sostmann to take over from Peter F. Schmid as CEO of Visable Group on January 1, 20262.12.2025 09:35:00 CET | Press release

(Hamburg, Germany) – After more than 13 years at the helm of Visable, Peter F. Schmid will hand over leadership of the Visable Group to Patrick Sostmann, who has been CCO at Visable since June 2025, on January 1, 2026. Visable operates the B2B marketplaces wer liefert was (wlw) and europages. The handover at the top underscores the company's continuous development and its close partnership with Alibaba.com. Sostmann will continue to drive forward the strategy based on AI investments and user orientation, thereby expanding the B2B marketplaces into European market leaders in digital B2B business. Over the past 13 years, Peter F. Schmid has transformed the long-established German business directory wer liefert was (wlw) into the internationally active digital company Visable, which now operates the two leading B2B marketplaces europages and wer liefert was (wlw). The last key milestone was Alibaba.com becoming majority shareholder in 2023. With these steps, Peter F. Schmid has set the co

Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award18.11.2025 16:00:00 CET | Press release

Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye